Orchestra BioMed Holdings OBIO
NASDAQ OBIO
$5.59 +0.12 (+2.19%)
At close: Oct 23, 2026 · 4:00 PM EDT

Orchestra BioMed Holdings (OBIO) Short term Debt (2023)

Updated

Orchestra BioMed Holdings (OBIO) posted Short term Debt of $9.6 million for Q3 2023.

Analysis

Orchestra BioMed Holdings (OBIO) Short term Debt (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.13 Bn 229.16 Bn 4.88 Bn
2 Abbott Laboratories 180.31 Bn 150.74 Bn 7.27 Bn
3 Danaher 162.34 Bn 146.15 Bn 3.61 Bn
4 Intuitive Surgical 158.13 Bn 138.42 Bn 2.08 Bn
5 Medtronic 122.37 Bn 87.63 Bn 6.34 Bn
6 Stryker 117.89 Bn 104.00 Bn 4.50 Bn
7 Boston Scientific 67.15 Bn 61.92 Bn 3.85 Bn
8 Becton Dickinson 54.68 Bn 51.83 Bn 2.32 Bn
9 Edwards Lifesciences 51.43 Bn 35.44 Bn 1.35 Bn
10 Orchestra BioMed Holdings 354.80 Mn -51.90 Mn 63,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 9.60 Mn
API Access

Orchestra BioMed Holdings Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=OBIO&period=max&api_key=YOUR_API_KEY